GRI Bio to present Phase 2a IPF data at Boston summit
Tweet Send to a Friend
GRI Bio, Inc. (NASDAQ: GRI) announced that its Chief Executive Officer Marc Hertz and Chief Scientific Officer Vipin Kumar will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


